I-gel Plus Supraglottic Airway Device for Elective Laparoscopic Surgery
1 other identifier
observational
48
1 country
1
Brief Summary
i-gel Plus is a novel supraglottic airway device (SGA). Feasibility of second-generation SGAs in patients undergoing elective laparoscopic surgery has been demonstrated in various studies. During laparoscopic surgery intrabdominal pressure is increased by capnoperitoneum and frequently minute ventilation has to be adopted to counteract hypercapnia, and higher inspiratory peak pressures have to be expected. It is uncertain, however, if the i-gel Plus facilitates appropriate ventilation with low leakage volumes in patients undergoing laparoscopic surgery. The primary aim of this single-center non-inferiority study is to assess the leak fraction of the i-gel Plus under conditions of capnoperitoneum (with and without Trendelenburg position) and to compare it with baseline conditions. Secondary aims are to assess secondary outcome parameters during capnoperitoneum (with and without Trendelenburg position) and to compare them with baseline conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 16, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 3, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 3, 2025
CompletedJune 8, 2025
June 1, 2025
4 months
September 16, 2024
June 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Leak fraction
Ventilation parameter - volume per tidal volume
3 houres
Secondary Outcomes (19)
Oropharyngeal seal pressure [cm H2O]
3 houres
Leakage volume (ml)
3 houres
Tidal volume (ml)
3 houres
Inspiratory peak pressure (cm H2O)
3 houres
Positive endexpiratory pressure (PEEP) (cm H2O)
3 houres
- +14 more secondary outcomes
Study Arms (1)
Patients undergoing laparoscopic surgery
Measurement of primary and secondary outcome parameters at different time points during the procedure.
Eligibility Criteria
Patients undergoing elective laparoscopic surgery with i-gel Plus used for airway management
You may qualify if:
- Patients scheduling for elective laparoscopic surgery
- Planned airway management using a SGA
- Adult patients (age 18-89 years)
- ASA physical status 1-3
You may not qualify if:
- Pregnant or breastfeeding women
- Non-fasted patients
- Increased risk of aspiration or other contraindications for supraglottic mask ventilation
- Body mass index (BMI) \>35 kg/m2
- Inability to understand or sign informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Center Hamburg-Eppendorf
Hamburg, Hamburg, 20246, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Martin Petzoldt, MD
Universitätsklinikum Hamburg-Eppendorf
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 16, 2024
First Posted
September 19, 2024
Study Start
October 1, 2024
Primary Completion
February 3, 2025
Study Completion
February 3, 2025
Last Updated
June 8, 2025
Record last verified: 2025-06